Evidence map›Paper›PMID 31124676›Full record

ArticleJournal of the American Chemical Society2019

Enantioselective Markovnikov Addition of Carbamates to Allylic Alcohols for the Construction of α-Secondary and α-Tertiary Amines.

Ana Bahamonde, Buthainah Al Rifaie, Victor Martín-Heras, Jamie R Allen, Matthew S Sigman

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. AsymmetricJournal of the American Chemical Society · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana BahamondeDepartment of Chemistry , University of Utah , 315 S. 1400 E , Salt Lake City , Utah 84112 , United States.ORCID 0000-0002-7713-1901
Buthainah Al RifaieDepartment of Chemistry , University of Utah , 315 S. 1400 E , Salt Lake City , Utah 84112 , United States.
Victor Martín-HerasDepartment of Chemistry , University of Utah , 315 S. 1400 E , Salt Lake City , Utah 84112 , United States.
Jamie R AllenDepartment of Chemistry , University of Utah , 315 S. 1400 E , Salt Lake City , Utah 84112 , United States.
Matthew S SigmanDepartment of Chemistry , University of Utah , 315 S. 1400 E , Salt Lake City , Utah 84112 , United States.ORCID 0000-0002-5746-8830

Funding

Pd-Catalyzed Olefin Functionalization Reactions for Organic SynthesisR01GM063540 · NIGMS · UNIVERSITY OF UTAH · PI SIGMAN, MATTHEW S · 2002 to 2019
$5.3M
Pd-Catalyzed Olefin Functionalization Reactions for Organic SynthesisR56GM063540 · NIGMS · UNIVERSITY OF UTAH · PI SIGMAN, MATTHEW S · 2007 to 2007
$276k
NIGMS NIH HHS R01 GM063540NIGMS NIH HHS R56 GM063540
6 · The paper itself

Abstract

Herein we describe the development of a Pd-catalyzed enantioselective Markovnikov addition of carbamates to allylic alcohols for the construction of α-tertiary and α-secondary amines. The reaction affords a range of β-amino alcohols, after reduction of the aldehyde in situ, which contain a variety of functional groups in moderate yields and moderate to good enantioselectivities. These products can be readily oxidized to β-amino acids, valuable building blocks for the synthesis of biologically active compounds. Mechanistic studies indicate that the C-N bond formation occurs via a syn amino-palladation mechanism, an insight which may guide future reaction development given the limited number of enantioselective syntheses of α-tertiary amines.

Indexed as

AlcoholsAlkenesAminesCarbamatesStereoisomerismAlcoholsAlkenesAminesCarbamates

Identifiers

PMID31124676
PMCPMC6583784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.